Breeze Holdings Acquisition Corp.
Status: Live Deal
U=S+W+R
W=S@11.5
R=S/20
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | Nov 23, 2020 |
| CEO | J. Douglas Ramsey, Ph.D. |
| Left Lead | I-Bankers Securities |
| IPO Cash in Trust | 101.5% |
| SPAC Tenor | 12 + 3 + 3 + 4 + 6 + 6 + 9 + 6 |
| IPO Sector |
Energy
Assets used in exploring, developing, producing, transporting, storing, gathering, processing, fractionating, refining, distributing or marketing of natural gas, natural gas liquids, crude oil or refined products in North America |
| IPO Geography | US/Canada |
| Target Company | YD Biopharma |
| Deal Announced | Sep 25, 2024 |
| Deal Size, $M | $694.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Jun 21, 2024 |
BRZH
BREZU
BRZHW
BREZR
| Price | $11.50 |
|---|---|
| Last closing price | $11.50 |
| H/L, today | $11.50 / $11.55 |
| Volume, today | 2,026 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Breeze Holdings Acquisition Corp.:
- Structure and cap table
- 7 directors & officers
- 38 filings and events
- 4 underwriters
- 1 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| J. Douglas Ramsey, Ph.D. | 60 | Chairman, CEO and CFO |
| Russell D. Griffin | 56 | President and Director |
| Charles C. Ross, P.E. | 63 | COO |
| Dan Hunt | 43 | Director |
| Albert S. McLelland | 61 | Director |
| Robert L. Thomas | 60 | Director |
| Bill Stark | 64 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| I-Bankers Securities | BR | 6,450,000 | units |
| Northland Capital Markets | 2,500,000 | ||
| Ingalls & Snyder | 1,000,000 | ||
| EarlyBirdCapital | 50,000 | ||
| 10,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| BCMA | 2.75 | % |
Sign in to view more advisor data.